Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma
Clinical trial NCT03951571 · COMPLETED
Trial details
- NCT number
- NCT03951571
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-13
- Primary completion
- 2022-06-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.